4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001468316-26-000002
Director sold 10,312 shares at $7.60 ($78,371)
- Director acquired 15,598 shares (option exercise)
- Director acquired 5,208 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Raykov Rosty Director | 2025-12-31 | Grant or award 10b5-1 | +5,208 | 82,734 | D: show line 1 in the form | ||
| Raykov Rosty Director | 2026-01-02 | Option exercise 10b5-1 | +15,598 | $2.45 | $38,215 | 98,332 | D: show line 2 in the form |
| Raykov Rosty Director | 2026-01-02 | Sale 10b5-1 | −10,312 | $7.60 | $78,371 | 88,020 | D: show line 3 in the form |
| Open-market sales · 10,312 sh · avg $7.60 · $78,371 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Raykov Rosty Director | 2026-01-02 | Option exercise · Stock Options 10b5-1 | −15,598 | $2.45 | $38,215 | 1,618,586 | D: show line 4 in the form |
Loading xslF345X05/form4-01052026_040101.xml…